Aflac Inc Stock Price, News & Analysis

Aflac reported Q2 2022 revenues of $5.4 billion, down from $5.6 billion a year ago. Net earnings rose to $1.4 billion ($2.16/share) from $1.1 billion ($1.62/share) due to $564 million in net investment gains. Adjusted earnings decreased 13.1% to $939 million, impacted by a weaker yen and higher expenses. Shareholders' equity fell to $26.4 billion from $33.7 billion in 2021. Aflac Japan saw a 4.2% decline in net earned premiums in yen, while Aflac U.S. reported a 1.0% decline. The company declared a dividend of $0.40 per share, payable on September 1, 2022.

Aflac Incorporated expresses profound sadness over the loss of former Japanese Prime Minister Shinzo Abe, who was instrumental in enhancing Japan's economy and advocating for women's leadership through his 'womenomics' policy. The company honors his legacy and extends condolences to his family and the people of Japan. Aflac, a leading provider of supplemental health insurance, serves over 50 million people and is recognized for its commitment to social responsibility and ethical practices, being named one of the World's Most Admired Companies and included in the Dow Jones Sustainability North America Index.

Aflac Incorporated (NYSE: AFL) announced it will release its second quarter 2022 financial results after market close on August 1, 2022. The release will include earnings materials and a video from CFO Max Brodén, available on the company's Investor Relations website. A conference call is scheduled for 8:00 a.m. (ET) on August 2, 2022, where executives will discuss the results and future outlook. Aflac serves over 50 million people, leading in supplemental health insurance in the U.S. and medical insurance in Japan.

AM Best has upgraded the Long-Term Issuer Credit Rating (ICR) of Aflac Incorporated and its subsidiaries, including Aflac Life Insurance Japan, to 'aa' from 'aa-' while affirming the Financial Strength Rating (FSR) of A+. The outlook for both ratings is now stable. The upgrade reflects Aflac's robust risk management capabilities, strong balance sheet strength, and strong operating performance. Aflac continues to lead in medical insurance in Japan and marketing supplemental insurance in the U.S. The company is focused on growth in various insurance sectors, leveraging technology for direct-to-consumer engagement.

Aflac Incorporated has launched a redesigned Group Critical Illness Insurance to better meet the evolving needs of workers in a post-pandemic world. The new product offers enhanced coverage options for acute and chronic conditions, including serious health events, infectious diseases, and mental illnesses. It features customizable benefits like hospitalization for infectious diseases and expanded health screenings. This innovation aims to support employers in maintaining a robust benefits program while addressing rising mental health concerns among employees. Aflac remains a leader in voluntary insurance products.

Aflac Incorporated (NYSE: AFL) reported Q1 2022 revenues of $5.3 billion, down from $5.9 billion in Q1 2021. Net earnings decreased to $1.0 billion ($1.58 per share) from $1.3 billion ($1.87 per share). Adjusted earnings fell 12.4% to $927 million, with an adjusted EPS of $1.42. Aflac Japan's net earned premiums dropped 4.3% in yen, while U.S. premiums declined 0.6%. The company repurchased $500 million in shares and declared a quarterly dividend of $0.40 per share, reflecting a 21.2% increase. The outlook remains cautiously optimistic amid ongoing pandemic challenges.